A group of former Motorola employees is claiming that their exposure to harmful chemicals while producing semiconductors has harmed their children. The 71 plaintiffs worked at a plants in Schaumburg and Arizona between 1965 and 2007. They claim that Motorola officials were aware of the dangers the chemicals posed to the employee’s potential offspring but did not warn the workers. The suit says the children suffer from various problems such as cerebral palsy, autism, blindness, spina bifida, language delays and epilepsy.

A recall has been issued of 30,000 Nap Nanny baby recliners due to the risk of a baby falling over one of the sides and becoming entangled in the straps. The recall comes after an infant became caught between the recliner and the crib bumper and died. The recliners were manufactured by Baby Matters LLC and sold at retail stores across the country

A San Diego jury will decide this week if Pizza Hut is liable for a November 2008 accident involving one of their drivers. The accident left a mother and daughter severely injured. According to the lawsuit, driver had a seizure while driving during work, causing her to black out and crash into the car containing the mother and child. The lawsuit claims that Pizza Hut should have known that their employee was at risk for seizures and has the responsibility of putting safe drivers on the road. The driver was eventually dropped from the lawsuit.

A Washington State man has been awarded $5.8 million in a lawsuit he filed against another man who shot him four times in 2008. The Plaintiff claimed in his lawsuit that the defendant shot him during an altercation between the two, but the defendant stated at his trial he was merely acting in self defense. As a result of the gunshot wounds, the plaintiff required 14 surgeries and has millions of dollars in medical bills. The defendant is currently serving nine months in prison for second-degree assault

More issues have been uncovered by federal investigators at another Johnson & Johnson plant. The Lancaster, Pa., plant, which produces heartburn medications, was cited with quality control problems and chaotic record keeping, along with complaints from customers that the medications were ineffective or not in the properly marked bottles. While no recall has been issued, inspectors found that the Lancaster plant “could not ensure that drugs produced there were up to standard.” The Lancaster plant is the third J&J plant to be flagged by the F.D.A. this year.

A Florida jury has ordered a local nursing home to pay $114 million to the family of a 76-year-old woman who was allegedly abused while staying at the home, and that abuse led to her death. According to the lawsuit,  the woman suffered “pressure sores, overmedication, malnourishment and dehydration” during her stay at Integrated Health Services in Auburndale, Fla. The jury awarded $14 million in damages and $100 million in punitive damages to Jackson’s family.

Former NFL center LeCharles Bentley has filed a lawsuit against the Cleveland Browns over a staph infection he contracted while using the team facilities for rehabilitation. The lawsuit claims that Bentley was not made aware that numerous other players had contracted staph infections in the past from the same facility. Bentley is accusing the team of fraud and negligent misrepresentation in the suit.

More than 90,000 pounds of frozen chicken nuggets have been recalled after bits of blue plastic were found in them. Georgia-based Perdue Farms announced the voluntary recall earlier this week. No injuries have yet been reported involving the product, which is sold at Wal-Mart as Great Value Fully Cooked Chicken Nuggets.

A lawsuit has been filed over the death of a New York City track worker who was electrocuted on an exposed third rail in Queens. The man’s wife filed the suit, claiming the city failed to protect the workers on the rail the day her husband died. “Third-rail protecting boards were removed and there was no signage or lights alerting employees of the exposed third rail,” the suit states. The lawsuit seeks unspecified damages

A committee within the F.D.A. has advised the agency to denounce its marketing approval of the popular cancer drug Avastin for treating breast cancer because “new trials showed no apparent benefit from the drug.” The committee found that new trials of the drug, which is combined with the breast cancer drug paclitaxel to treat metastatic breast cancer, actually showed that survival rates decreased slightly for women due to complications from the drugs. If the F.D.A. decides to follow the committee recommendation, it would not affect marketing of the drug for brain, lung, colon and kidney cancer.